Nina Lahanis joined PrimeVigilance as in 2023 and brings a strong background in global pharmacovigilance, medical communications, regulatory compliance, medical education and technology.
With 13+ years of pharmacovigilance expertise and more than 30 years in biotech/pharma across R&D and marketing, Nina’s leadership expertise spans from the research lab to post-commercialization. Nina has led global drug safety operations, provided educational product training, contributed to new and organic business development, and successfully streamlined integration processes for multiple organizations.
Before joining PrimeVigilance, Nina has held global PV operational leadership positions at EVERSANA, Syneos Health, PPD, and Ashfield. Nina is a strong leadership role model for internal teams as well as client teams.
Nina holds a Bachelor of Science degree in microbiology from the University of Wisconsin and has completed master’s degree coursework in molecular biology for Harvard University.
